Clinical Trial Update: Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis [NA]

View source ↗

Summary

A clinical trial evaluating a 0.03% chlorhexidine mouth rinse for peri-implant mucositis has completed. The sponsor is Universidad Complutense de Madrid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peri-implant Mucositis

Drugs mentioned

• Chlorhexidine gluconate mouth rinse 0.03% (chlorhexidine gluconate mouth rinse)

Snippet

Sponsor: Universidad Complutense de Madrid | Conditions: Peri-implant Mucositis | NA | Status: COMPLETED